How to use the speech recognition tool?
Validation of standardized test protocols to assess the impact of visual pathologies in daily life activities
Validation of standardized test protocols to assess the impact of visual pathologies in daily life activities.
Status of the trial: Active, Not recruiting
Orphan Drug Recognition: No
- Opening Date: 2019-10-04
- Closing Date: 2021-03-01
Inclusion: Gr1 affected patients: Diagnosed non-syndromic pigmentary retinopathy (RP) Gr 2 healthy patients: Visual acuity of both corrected eyes (glasses, lenses) greater than or equal to 8/10 (or ≤ 0.1 logMAR)
Exclusion: MMSE score without visual item ≤ 20/25 for RP patients MMSE score with visual item ≤ 25/30 for healthy volunteers Pregnant woman
Funder Type: private, public
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
- Retinal Rare Eye Diseases (WG1)
This ERN is supported by: